zepbound vs semaglutide Wegovy: A Comprehensive Guide to New Weight Loss Medications Zepbound Versus Wegovy: Head-to-Head Trial
Description
COURAGE to EMBRAZE and BELIEVE Three recent Phase 2 trials focused on helping patients preserve lean mass while losing weight read out recently
The Phase 2 data is actually quite clean from a cardiovascular standpoint
As a result, they may pose higher risks to patients, including variability in potency, contamination, or improper formulation
To drugi lek - po Wegovy - z grupy analogw GLP-1 dostpny w postaci tabletek, ktry uzyska zatwierdzenie przez FDA
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." New England Journal of Medicine 2023;389:514526 Wilding JPH, et al
Kumar D, et al
